Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development

N Kushnir, SJ Streatfield, V Yusibov - Vaccine, 2012 - Elsevier
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …
被引用次数：683 相关文章

[引用][C] Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

N KUSHNIR, SJ STREATFIELD, V YUSIBOV - Vaccine, 2012 - pascal-francis.inist.fr
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production
systems and advances in clinical development CNRS Inist Pascal-Francis CNRS Pascal …

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

N Kushnir, SJ Streatfield, V Yusibov - 2012 - publica.fraunhofer.de
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …
[HTML] nih.gov

[HTML][HTML] Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

N Kushnir, SJ Streatfield, V Yusibov - Vaccine, 2012 - ncbi.nlm.nih.gov
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …

Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

N Kushnir, SJ Streatfield, V Yusibov - Vaccine, 2012 - europepmc.org
abstract Virus-like particles (VLPs) are a class of subunit vaccines that differentiate
themselves from soluble recombinant antigens by stronger protective immunogenicity …

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

N Kushnir, SJ Streatfield, V Yusibov - Vaccine, 2012 - infona.pl
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …

Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

N Kushnir, SJ Streatfield, V Yusibov - 2012 - cabidigitallibrary.org
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …

Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development

N Kushnir, SJ Streatfield, V Yusibov - Vaccine, 2012 - pubmed.ncbi.nlm.nih.gov
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …

[引用][C] Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

N Kushnir, SJ Streatfield, V Yusibov - Vaccine, 2012 - cir.nii.ac.jp
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production
systems and advances in clinical development | CiNii Research CiNii 国立情報学研究所 学術 …

[引用][C] Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

N Kushnir, SJ Streatfield, V Yusibov - Vaccine, 2012 - Elsevier Limited